Home LiteratureArticle Details
PMID: 6829166 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Entry of murine retrovirus into mouse fibroblasts.

Virology ·Vol. 125 ·No. 1 ·1983-02-00 ·Pages 85-98

Andersen KB, Nexø BA

Abstract

We have studied the entry of murine retrovirus into mouse fibroblasts by following the fate of both radioactively (protein) labeled virus particles and infectious virus particles. Physical and infectious particles bound to the cell surface with a half time of 1.5-2 hr. Both types of particles were internalized with a half time of approximately 3 hr as measured by the resistance to externally added proteases. The binding proceeded both at 37 and 0 degrees, whereas the internalization was blocked at 0 degrees. The internalized physical particles followed two routes: they either were degraded or remained stable in the cell. Degradation was blocked by lysosomotropic bases and is therefore believed to occur in the lysosomes. Infection could also be inhibited by lysosomotropic bases when present in the first hours after the internalization, indicating that the infectious route also is leading through the lysosomes or another acidic compartment of the cell.

MeSH Terms
Animals Cell Line Cell Membrane/microbiology Fibroblasts/microbiology Kinetics Lysosomes/metabolism,microbiology Mice Retroviridae/metabolism,physiology Temperature Trypsin/pharmacology Viral Proteins/metabolism
Chemicals
Viral Proteins Trypsin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Andersen K B
Nexø B A
Article Info
Journal
Virology
Abbr.
Virology
ISSN
0042-6822
Published
1983-02-00
Pages
85-98
Language
English
Region
United States
NLM ID
0110674
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]